These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11099737)

  • 1. Failure to detect amphetamine or 1-amino-3-phenylpropane in humans or rats receiving the MAO inhibitor tranylcypromine.
    Sherry RL; Rauw G; McKenna KF; Paetsch PR; Coutts RT; Baker GB
    J Affect Disord; 2000 Dec; 61(1-2):23-9. PubMed ID: 11099737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranylcypromine ('Parnate') overdose: measurement of tranylcypromine concentrations and MAO inhibitory activity and identification of amphetamines in plasma.
    Youdim MB; Aronson JK; Blau K; Green AR; Grahame-Smith DG
    Psychol Med; 1979 May; 9(2):377-82. PubMed ID: 472083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination Between Drug Abuse and Medical Therapy: Case report of a tranylcypromine overdose-related fatality.
    Akhgari M; Jokar F; Etemadi-Aleagha A; Ghasemi A
    Sultan Qaboos Univ Med J; 2017 May; 17(2):e213-e217. PubMed ID: 28690895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of tranylcypromine enantiomers in healthy subjects after oral administration of racemic drug and the single enantiomers.
    Weber-Grandke H; Hahn G; Mutschler E; Möhrke W; Langguth P; Spahn-Langguth H
    Br J Clin Pharmacol; 1993 Oct; 36(4):363-5. PubMed ID: 12959316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is tranylcypromine really metabolized to amphetamine?
    Jefferson JW
    J Clin Psychiatry; 1992 Dec; 53(12):450-1. PubMed ID: 1487476
    [No Abstract]   [Full Text] [Related]  

  • 6. N-(2-cyanoethyl)tranylcypromine, a potential prodrug of tranylcypromine: its disposition and interaction with catecholamine neurotransmitters in brain.
    Nazarali AJ; Baker GB; Coutts RT; Wong TF
    Pharm Res; 1987 Feb; 4(1):16-20. PubMed ID: 3508523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An enzymatic assay for the MAO-B inhibitor selegiline in plasma.
    Mahmood I; Neau SH; Mason WD
    J Pharm Biomed Anal; 1994 Jul; 12(7):895-9. PubMed ID: 7981318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electron-capture gas chromatographic procedure for simultaneous determination of amphetamine and N-methylamphetamine.
    Paetsch PR; Baker GB; Caffaro LE; Greenshaw AJ; Rauw GA; Coutts RT
    J Chromatogr; 1992 Jan; 573(2):313-7. PubMed ID: 1601966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One fatal and one nonfatal intoxication with tranylcypromine. Absence of amphetamines as metabolites.
    Iwersen S; Schmoldt A
    J Anal Toxicol; 1996 Sep; 20(5):301-4. PubMed ID: 8872238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gas chromatographic procedure for simultaneous determination of selegiline metabolites, amphetamine, methamphetamine and demethyl-deprenyl in pig plasma.
    Szebeni G; Lengyel J; Székács G; Magyar K; Gaál J; Szatmári I
    Acta Physiol Hung; 1995; 83(2):135-41. PubMed ID: 8588500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical and neuropharmacological properties of 4-fluorotranylcypromine.
    Coutts RT; Rao TS; Baker GB; Micetich RG; Hall TW
    Cell Mol Neurobiol; 1987 Sep; 7(3):271-90. PubMed ID: 3440283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A gas chromatographic procedure for separation and quantitation of the enantiomers of the antidepressant tranylcypromine.
    Aspeslet LJ; Baker GB; Coutts RT; Mousseau DD
    Biochem Pharmacol; 1992 Nov; 44(9):1894-7. PubMed ID: 1449543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of monoamine oxidase inhibitors.
    Baker GB; Urichuk LJ; McKenna KF; Kennedy SH
    Cell Mol Neurobiol; 1999 Jun; 19(3):411-26. PubMed ID: 10319194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of monoamine oxidase inhibitors and amphetamine on hypothermia produced by halothane.
    Feldberg W; Lang WJ
    Br J Pharmacol; 1970 Jan; 38(1):181-91. PubMed ID: 4391731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Demonstration of the "group toxicity" of certain monoamino-oxidase inhibitors. Comparison of their mode of action with that of amphetamine].
    HALPERN BN; DRUDI-BARACCO C; BESSIRARD D
    C R Seances Soc Biol Fil; 1962; 156():1238-45. PubMed ID: 13952219
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatic and extrahepatic metabolism of deprenyl, a selective monoamine oxidase (MAO) B inhibitor, of amphetamines in rats: sex and strain differences.
    Yoshida T; Oguro T; Kuroiwa Y
    Xenobiotica; 1987 Aug; 17(8):957-63. PubMed ID: 3118583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of monoamine oxidase inhibitors.
    Baker GB; Coutts RT
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):395-403. PubMed ID: 2664891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MECHANISM OF ACTION OF MONOAMINE OXIDASE INHIBITORS IN ENHANCING AMPHETAMINE TOXICITY.
    BRITTAIN RT; JACK D; SPENCER PS
    J Pharm Pharmacol; 1964 Aug; 16():565-7. PubMed ID: 14223999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.